You are here: Industry Insights > lupin

News List

Lupin Pharma Canada, Endoceutics to partner for commercialisation of Intrarosa expresspharma
March 10, 2021
It is indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of Prasterone.
Is Women’s Health gaining momentum? expresspharma
March 09, 2021
In Express Pharma’s Women’s Day Special issue, some industry observers and pharma stakeholders share insights on opportunities, challenges and focus on the women’s health segment as it continues to evolve and advance.
Lupin launches generic drug to treat Wilson’s disease in US mkt expresspharma
March 03, 2021
Lupin has launched Penicillamine tablets, used to treat Wilson’s disease, in the US market.The company has launched a generic product in the market after having received approval from the US and Drug Administration (US FDA) earlier.
Industry welcomes PLI 2.0 Scheme, awaits implementation details expresspharma
February 26, 2021
Stakeholders highlight that this scheme will help play to our strengths, work towards making the pharma industry more self-reliant, generate employment and usher more affordability in healthcare.
Lupin gets US FDA approval for Droxidopa Capsules expresspharma
February 20, 2021
Lupin announced that it has received approval for its Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, from the United States Food and Drug Administration, to market a generic equivalent of Northera Capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck.
Lupin launches Posaconazole Delayed-Release Tablets expresspharma
February 18, 2021
They are indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised.
Lupin, Aurobindo recall drugs in US market expresspharma
February 18, 2021
Lupin Pharma is recalling 46,479 bottles of Oseltamivir Phosphate for Oral Suspension while AuroMedics Pharma, a unit of Aurobindo Pharma, is recalling 3,094 cartons of Acetaminophen injection.
Lupin gets US FDA nod for Tavaborole Topical Solution expresspharma
February 10, 2021
It is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
Lupin appoints Mark D McDade as new Independent Director expresspharma
February 03, 2021
Lupin has announced the appointment of Mark D McDade as an Independent Director effective from January 28, 2021.
Lupin gets USFDA approval for Sevelamer Carbonate Tablets expresspharma
January 26, 2021
They are indicated for the control of serum phosphorus in adults and children six years of age and older with chronic kidney disease on dialysis.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page